News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Explore the Do’s and Don’ts of Communication on Advanced Breast Cancer – SPCC
SPCC/LinkedIn
Nov 30, 2024, 09:29

Explore the Do’s and Don’ts of Communication on Advanced Breast Cancer – SPCC

SPCC posted on LinkedIn:

“HCPs, PATIENTS and ADVOCATES:
Join the ABC Global Alliance at SABCS24 on 10 Dec to explore the Do’s and Don’ts of Communication on Advanced Breast Cancer.

This workshop, co-hosted by the ABC Global Alliance and the MBC Alliance, offers tips for navigating challenging health topics.

Open to registered participants of SABCS! Register here.”

ABC Global Alliance cancer Do's and Don'ts of Communication on Advanced Breast Cancer MBC Alliance OncoDaily Oncology SABCS24 SPCC
Special Coverage
Science
Jan 10, 2025, 05:40
Article of the Week, Suggested by the BPDCN International Registry
Career
Jan 10, 2025, 05:39
OncoInfluencers to Follow on Social Media: Gregg Margolis
Blog
Jan 9, 2025, 17:18
Fumiko Ladd Chino: 2025  ASCO JCO Journals Editorial Fellow Application is OPEN
Insight
Jan 9, 2025, 17:18
Jessica MacIntyre: Excited for this year’s 50th Annual Oncology Nursing Society Congress
Blog
Jan 9, 2025, 17:04
Mehdi Hamadani: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide
Blog
Jan 9, 2025, 16:48
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
Blog
Jan 9, 2025, 16:41
Elisabetta Munzone: Harmonizing EHRs in Italy for Better Healthcare Outcomes and Cost Reduction
Blog
Jan 9, 2025, 16:38
Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
Blog
Jan 9, 2025, 16:35
Ahmed Kotb: Ph-like ALL Signaling Pathways and Targets
Blog
Jan 9, 2025, 16:32
Priorities of ESTRO for engagement within the EURAMED framework
Blog
Jan 9, 2025, 16:29
Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib
Blog
Jan 9, 2025, 16:22
Isabel Preeshagul: Survey on addressing barriers to clinical trial accrual in patients with lung cancer